We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK’s OTC Facility Cited for Quality Control, Complaint Failures
GSK’s OTC Facility Cited for Quality Control, Complaint Failures
GlaxoSmithKline’s Aiken, S.C., plant received a four-observation Form 483 from the FDA for failing to follow quality control procedures and other GMP violations.